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Differentiating neurons process the mechanical stimulus by exerting the protrusive forces through
lamellipodia and filopodia. We used optical tweezers, video imaging and immunocytochemistry to analyze
the role of non-muscle myosin-II on the protrusive force exerted by lamellipodia and filopodia from
developing growth cones (GCs) of isolated Dorsal Root Ganglia (DRG) neurons. When the activity of
myosin-II was inhibited by 30 mM Blebbistatin protrusion/retraction cycles of lamellipodia slowed down
and during retraction lamellipodia could not lift up axially as in control condition. Inhibition of actin
polymerization with 25 nM Cytochalasin-D and of microtubule polymerization with 500 nM Nocodazole
slowed down the protrusion/retraction cycles, but onlyCytochalasin-D decreased lamellipodia axialmotion.
The force exerted by lamellipodia treated with Blebbistatin decreased by 50%, but, surprisingly, the force
exerted by filopodia increased by 20-50%. The concomitant disruption of microtubules caused by
Nocodazole abolished the increase of the force exerted by filopodia treated with Blebbistatin. These results
suggest that; i- Myosin-II controls the force exerted by lamellipodia and filopodia; ii- contractions of the
actomyosin complex formed by filaments of actin and myosin have an active role in ruffle formation; iii-
myosin-II is an essential component of the structural stability of GCs architecture.
D
uring development, neurons are able to self-organize in precisely wired networks and are able to establish
the appropriate synaptic connections. Neuronal navigation requires the existence of highly motile struc-
tures able to probe the mechanical properties of the surrounding environment and to search for the
chemical cues leading to the formation of correct synaptic connections1,2. Neuronal exploration is guided by
growth cones (GCs) located at the neurite tips3,4. GCs are composed of lamellipodia of different sizes, depending
on the cell type and species fromwhich thin filopodia with a submicron diameter emerge5. The primary source of
motility in GCs is the polymerization of actin filaments6,7, controlled by a large set of regulatory proteins, such as
Arp2/3,WASP, etc8 andmolecularmotors seem to participate in the overall process by controlling several aspects
of the process.
The addition of actin monomers/oligomers to actin filaments in close contact with the membrane pushes the
cellular membrane forward exerting a protrusive force6,9. An important determinant of force generation is the
turnover of actin filaments, during which actinmonomers or small oligomers are added to the barbed end of actin
filaments (polymerization) and are removed from the other end (depolymerization). In this process the non-
muscle myosin-II plays an important role: indeed myosin-II controls the retrograde flow of actin polymers by
severing the actin filaments at their pointed end, providing the necessary treadmilling mechanism10. Myosins
constitute a superfamily of motor proteins with major roles in several cellular processes such as cell adhesion,
migration and division11. Myosin molecules, like all motor proteins, can walk along, propel and slide by other
molecules and can produce tension on actin filaments. Generation of tension and force requiresmetabolic energy,
usually provided by ATP hydrolysis and therefore myosins have appropriate catalytic sites in their amino-
terminal (head) region. Myosin can associate to actin filaments to form the actomyosin complex, which can
generate force. Like muscle myosin-II, non-muscle myosin-II (NMII) molecules are formed by three pairs of
peptides with different molecular weight and function11. The three myosin-II isoforms NMIIA, NMIIB and
NMIIC have similar structural and dynamical properties but have slightly different kinetics properties. Their
major difference seems to reside in their regulation properties and different proteins control them through
distinct phosphorylation sites11.
Myosin-II seems to be involved in the orchestration of actin polymerization/depolymerization but also of
microtubules (MTs) dynamics. Indeed, it has been shown that actin oligomers driven by myosin-II interact with
growing MTs and that myosin-II-dependent compressive force is necessary for MTs dynamics12 to form axons.
The existence of a coupling between actin and MT dynamics is also supported by the observation that inhibition
of myosin-II with Blebbistatin markedly accelerates axon growth and promotes the reorganization of both actin
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andMTs in GCs13. In this study we used Blebbistatin, selective potent
inhibitor ofmyosin-II to assess the effect of myosin-II on themotility
of the DRG GCs. Blebbistatin blocks the myosin in an ADP bound
state which precedes the force generating step and therefore inhibits
the actomyosin contraction14.
We have used Optical Tweezers (OT), to analyze the role of
myosin-II in the force generation of DRG GCs lamellipodia and
filopodia. OT provide a quantitative characterization of the exerted
force with millisecond time resolution and pN sensitivity15. We have
also used video imaging to characterize and quantify the 3D motion
of lamellipodia, during which lamellipodia lift up vertically by some
microns16. By combining these experimental methods with the use
of inhibitors of cytoskeletal functions and of immunocytochemistry,
we have explored the role of contractions of the actomyosin com-
plex in the protrusion/retraction cycles, observed in lamellipodia of
developing neurons. Here we confirm that myosin-II not only con-
trols the retrograde flow of actin10 but it is also an essential com-
ponent of the structural stability of GCs architecture regulating the
coupling of actin filaments and microtubules dynamics and plays a
fundamental role in the force generation of lamellipodia and - to
some extent - also in filopodia.
Results
Large and highly motile lamellipodia emerge from dissociated neu-
rons from DRG after 6–12 hours of culture17–19. These lamellipodia
can exert forces larger than 20 pN and their leading edge can move
with a speed of 30–100 nm/s19. In our preparation, motility is
restricted to lamellipodia and filopodia of dissociated neurons from
DRG, which do not migrate and their soma remains approximately
in the same position on the dish for several hours. After 2–3 days of
culture, dissociated neurons establish physical contacts and motility
of lamellipodia and filopodia is reduced. Therefore, we analyzed the
effect of inhibitors of, myosin-II (Blebbistatin), actin polymerization
(Cytochalasin-D) and microtubule polymerization (Nocodazole) on
lamellipodia and filopodia after 24–48 hours of culture, when their
motility is more pronounced.
The effect of Blebbistatin, Cytochalasin-D and Nocodazole on
lamellipodia protrusion/retraction cycles. Lamellipodia emerging
from the soma of DRG neurons protrude and collapse continuously
and their protrusion/retraction cycles were followed by video
imaging (see Methods). By analyzing these image sequences with
Algorithm I, described in the Methods section, the average
distance of the lamellipodium leading edge was measured from a
reference point (C) chosen at the base of the lamellipodium (see
Methods) and the periods of protrusion/retraction cycles were
calculated (red bars in Fig. 1). When 30 mM Blebbistatin was
added to the medium bathing of the neuronal culture, protrusion/
retraction cycles of lamellipodia could be observed but with a period
30–50% longer than in control condition and after 15 minutes
lamellipodia shrank (Fig. 1a and 1b). When a higher concentration
of Blebbistatin was used, such as 100 mM, lamellipodia shrankwithin
2–3 minutes and motility was completely suppressed.
In control condition, during protrusion/retraction cycles, lamelli-
podia also moved upwards by 2–5 mm: indeed, at a focal plane 3 or
4 mm above the coverslip their leading edge could be seen well in
focus. By using Algorithm II described in the Methods section, the
number of pixels of a lamellipodium in focus at different heights, i.e.
at 2, 3 and 4 mm above the coverslip, was counted and followed in
time (Fig. 1c). This algorithm allowed quantifying the extent of the
axial motion and the effect of different inhibitors of cytoskeletal
proteins on this axial motion. After the addition of 30 mM
Blebbistatin to the bathing medium, the period of protrusion/retrac-
tion cycles increased from an average of 96.1 6 3.3 s in control
condition to 136.76 5.9 s (Fig. 1b). Lamellipodia not only prolonged
the duration of their protrusion/retraction cycles (Fig. 1a and b) but
also reduced the average height reached during these cycles in the
presence of 30 mM Blebbistatin (Fig. 1c). Indeed, the fraction of
pixels in focus at 2 mm above the coverslip increased, while those
in focus at 3 and 4 mm above the coverslip decreased (Fig. 1c).
Treatment with a concentration of 100 mMBlebbistatin invariably
led to the suppression of lamellipodia motility. We also investigated
the effect of other inhibitors known to affect and abolishmotility, but
acting on different biochemical targets. Cytochalasin-D is a well-
known and specific inhibitor of actin filament polymerization20.
Cytochalasin-D bound to the barbed end of actin filaments blocking
the addition of new actinmonomers or oligomers. Concentrations of
Cytochalasin-D, such as 50 or 100 nM caused lamellipodia to shrink
completely and abolished almost entirely the GCs motility, con-
firming the fundamental role of actin filament polymerization.
Nocodazole inhibits the microtubules polymerization21 and, in our
experiments, lamellipodia motion was almost entirely abolished in
the presence of 1 mM of Nocodazole. Blebbistatin, Cytochalasin-D
and Nocodazole reduced lamellipodia motility but did not have the
same effect on lamellipodia and filopodia morphology: lamellipodia
treated with Cytochalasin-D shrank and showed the formation of
small ruffles but did not acquire the ‘filopodish’ appearance (Fig. 1d
and e) observed in lamellipodia treated with Blebbistatin (see
Discussion). Lamellipodia treated with Nocodazole shrank showing
neither small ruffles nor the filopodish appearance as seen in
Cytochalasin-D and Blebbistatin respectively (Fig. 1i and j).
Addition of 25 nM Cytochalasin-D and 500 nM Nocodazole did
not abolish the protrusion/retraction cycles (Fig. 1f and k).
The period of protrusion/retraction cycles increased from an aver-
age of 95.2 6 7.3 s in control condition to 131.5 6 9.8 s in the
presence of 25 nM Cytochalasin-D (Fig. 1g) and 110.9 6 5.0 s in
the presence of 500 nM Nocodazole (Fig. 1l). The same concentra-
tion of Cytochalasin-D also reduced the ability of treated lamellipo-
dia to lift up along the vertical direction during these protrusion/
retraction cycles: the fraction of edges seen in focus at focal planes
higher than 3 mm significantly decreased and lamellipodia edges
seen in focus at a plane 2 mm above the coverslip becamemuchmore
frequent (Fig. 1h). The application of 500 nM Nocodazole caused a
transient shrinkage of GCs, but, within a couple of minutes, lamelli-
podia were able to lift up in the vertical direction almost as in control
condition (Fig. 1m). This differential effect of Blebbistatin and
Cytochalasin-D versus Nocodazole indicates a major role of myo-
sin-II and actin polymerization in lamellipodia axial motion and a
minor role of microtubules.
The effect of Blebbistatin, Cytochalasin-D and Nocodazole on the
force exerted by lamellipodia. Having analyzed the effect of
Blebbistatin, Cytochalasin-D and Nocodazole on the kinetics of
protrusion/retraction cycles, we used OT to analyze changes of the
force exerted by lamellipodia and filopodia caused by these
inhibitors. Untreated lamellipodia pushed trapped beads (Fig. 2a–
c) exerting maximum forces up to 10–20 pN as previously
described22 and often a bead could be displaced out of the optical
trap. Lamellipodia of DRG treated with 30 mM Blebbistatin could
also pull and push a trapped bead (Fig. 2e–g) but with a lower force
(Fig. 2h).
The addition of 25 nM Cytochalasin-D and 500 nM of
Nocodazole caused lamellipodia to shrink, reduced neuronal mot-
ility and the amplitude of generated forces (Fig. 2i–p). In several
experiments we were able to measure the maximum force exerted
by the same lamellipodia in control condition and in the presence of
inhibitors. Thesemeasurements were then divided into four different
stereotyped behaviors: vertical push (VP), vertical retraction (VR),
lateral push (LP) and lateral retraction (LR), where vertical refers to
the push or pull of the bead in the axial direction (perpendicular to
the plane of the coverslip) and lateral refers to the push or pull of the
bead in the lateral direction (parallel to the plane of the coverslip)
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Figure 1 | The effect of Blebbistatin, Cytochalasin-D and Nocodazole on protrusion/retraction cycles. (a) Cycles of protrusion/retraction of
lamellipodia vs time. The dotted line represents the time of inhibitor addition. (b) Average periods of lamellipodia protrusion/retraction cycles in control
condition (red) and in the presence of 30 mMBlebbistatin (Bleb 30 mM, blue), fromn5 8 neurons. Student t-test showed that the data significantly differs
with respect to control, P, 0.005. Data represents mean 6 SEM. (c) The fraction of pixels in focus of lamellipodia in different focal planes (h 5 2, 3 and
4 mm) above the coverslip. Data averaged from 8 experiments. The vertical bar indicates the SEM and the vertical broken line indicates the time at which
the drug was added. (d–e) Images of lamellipodia emerging from aDRGneuron in control condition (d) and after treatment with 25 nMCytochalasin-D
(CD 25 nM) (e), Scale bar, 5 mm. (f–h) As in (a–c) but in the presence of 25 nM Cytochalasin-D, from n 5 10 neurons. (h) as in (c) but for 10
experiments. (i–j) Images of lamellipodia emerging from a DRG neuron in control condition (i) and after treatment with 500 nM Nocodazole (Noco
500 nM,). (k–m) As in (a–c) but in the presence of 500 nM Nocodazole, from n 5 8 neurons. (m) As in (c) but for 7 experiments. All the data were
checked with chi-square test for Normal distribution before applying the student’s t test.
www.nature.com/scientificreports
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Figure 2 | The effect of Blebbistatin, Cytochalasin-D and Nocodazole on the force generated by lamellipodia. (a) Low-resolution image of a bead
trapped in front of a lamellipodium emerging from the soma of aDRGneuron in control condition. Scale bar, 5 mm(b–c)High-resolution images during
a push. At t1 the bead is in the optical trap (b) and when the lamellipodium grows, at t2, it pushes the bead (c). The cross indicates the center of the optical
trap. Scale bar, 1 mm. (d) The three components Fx, Fy, and Fz of the force exerted when the lamellipodium pushes the bead. (e–h) As in (a–d) but in the
presence of Blebbistatin (Bleb 30 mM). (i–l) As in (a–d) but in the presence of Cytochalasin-D (CD 25 nM). (m–p) As in (a–d) but in the presence of
Nocodazole (Noco 500 nM). The trap stiffness is kx,y 5 0.10 pN/nm., kz 5 0.03 pN/nm. (q–t) Comparison of the force exerted by lamellipodia in control
condition (red), 30 mM Blebbistatin (blue), 25 nM Cytochalasin-D (black) and 500 nM Nocodazole (green) and in all four different stereotyped
behaviors: LP (lateral push), LR(lateral retraction), VP (vertical push) and VR (vertical retraction). In each case, by using the student t-test, the force
measured in the presence of inhibitors was lower than the onemeasured in control condition with a significance *P, 0.005. Data representmean6 SEM.
(u–x) Average Fv relationship, (FV)avg, normalized to Fmax for VP(u), LP(v), VR (w) and LR (x). All the data were checkedwith chi-square test for Normal
distribution before applying the student’s t test.
www.nature.com/scientificreports
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(Fig. 2q–t). In these experiments all tested inhibitors reduced the
force by about 50%, in case of LP. While in case of LR, Blebbistatin
and Cytochalasin-D reduced the force by 40–50%, but Nocodazole
reduced the force by 75% compared to control condition. For VP and
VR the force was decreased in Blebbistatin and Cytochalasin-D by
about 50% and in Nocodazole by more than 80% compared to con-
trol condition (Table 1). In the great majority of experiments, treat-
ment with 25 nM Cytochalasin-D and 500 nM of Nocodazole for
longer than 30–50 minutes completely abolished GCs motility.
The average Fv relationships (FV)avg were computed from the
measured displacements (see Methods). Fv relationships obtained
from a single experiment were normalized to Fmax and averaged to
obtain average Fv relationships, (FV)avg19. At the beginning, the bead
was in the trap far from the lamellipodia and its velocity was zero.
During push the lamellipodia leading edge moved toward the
trapped bead with constant velocity. Before coming to a solid contact
with the bead, the bead velocity increased but later - after complete
contact – beads and lamellipodia moved with the same velocity.
Therefore (FV)avg relationships after an initial rise of v exhibited a
flat shape, during which the mean velocity remained constant while
the force increased (Fig. 2u–x). The analysis of the Force-velocity
(Fv) relationships (Fig. 2u–x) shows that both inhibitors did not
modify the shape of the Fv relationships but reduced the maximal
velocity v for both vertical and lateral pushes and retractions.
Lamellipodia velocity was reduced more potently by 500 nM
Nocodazole than 25 nM Cytochalasin-D and 30 mM Blebbistatin
(compare green, black and blue traces in Fig. 2 u–x).
These results show that Nocodazole, Blebbistatin and Cytochalasin-D
reduce the maximal force exerted by protruding lamellipodia and the
maximal velocity of their leading edges.
Changes of noise during force generation with Blebbistatin and
Cytochalasin-D. A remarkable feature of force generation during
vertical and lateral push is the concomitant increase of noise when
the lamellipodia push the bead18. This increase of noise is not
present when the lamellipodium retracts, pulling the bead away
from the optical trap. We have previously shown18 that in
controlled GCs, the relation between the variance of the measured
displacement s2 and the exerted force F is upward convex and s2
increases from about 50 nm2 to 150 nm2 as the force also increases
(Fig. 3a, b and c, red traces) and that this increase of s2 is abolished
by Jasplakinolide, inhibiting actin filament depolymerisation23. In
GCs treated with 12.5 and 25 nM Cytochalasin-D the relation
between F and s2 was flat and almost no increase of s2 was
observed even when the force exceeded 8 pN (grey and black
traces in Fig. 3a). In the presence of 30 mM Blebbistatin, a small
increase of s2 from about 40 to 60 nm2 was observed (blue trace in
Fig. 3b). In case of 500 nM Nocodazole s2 increased from 30 to
70 nm2 (green trace in Fig. 3c).
Following bead adhesion to the lamellipodium membrane18, s2
could decrease to less than 6 nm2 and subsequently, when the lamel-
lipodium pushed the bead, forward and backward jumps constitut-
ing the elementary events underlying force generation appeared. In
the presence of 500 nM Nocodazole, 25 nM Cytochalasin-D, for-
ward and backward jumps could be observed but were less frequent
than in control condition (Fig. 3d and f). Also in the presence of
30 mMBlebbistatin forward and backward jumps were observed and
were more frequent (Fig. 3e and h) than those observed in the pres-
ence of Cytochalasin-D. The amplitude of forward j1 and backward
jumps j2 were exponentially distributed (Fig. 3g, h and i) and were
fitted by the equations A1 e2j1/j1* and A2 e2j-/j2*where A1 and A2
are the frequency of forward and backward jumps, respectively and
j1* and j2* are the mean amplitude of forward and backward jumps,
respectively. Mean values of these parameters obtained in control
condition and in the presence of Nocodazole, Cytochalasin-D and
Blebbistatin are shown in Table 2. In control condition the mean
values of j1* and j2* were 5.1 6 1.3 and 4.9 6 1.2 nm respectively
with corresponding rates A1 and A2 of 157.3 6 12.2 and 155.5 6
11.1 events/s respectively. In the presence of both Blebbistatin and
Cytochalasin-D themean values of forward and backward jumps j1*
and j2* decreased by about 50%, in agreement with the reduced or
absence of noise which increased during force generation caused by
the addition of the two inhibitors (Fig. 3a and b). These inhibitors,
however, had a different action on the jump frequency: larger con-
centrations of Cytochalasin-D progressively reduced A1, i.e. the rate
of the appearance of forward jumps but not of backward jumps, in
agreement with the known effect of Cytochalasin-D that blocks actin
filament polymerization20. Blebbistatin reduced both the forward
and backward rates A1 and A2. In the presence of Nocodazole the
mean values of the forward and backward jumps j1* and j2*
remained the same, but the jump frequency was reduced by more
than 60% (Fig. 3c and Table 2).
Blebbistatin makes filopodia able to exert a larger force. Noco-
dazole, Blebbistatin and Cytochalasin-D reduced the amplitude of
the force exerted by DRG lamellipodia, but, rather surprisingly, we
observed that the force exerted by filopodia treated with Blebbistatin
was larger than in untreated filopodia.
In control condition, when filopodia emerged from lamellipodia
(Fig. 4a), they moved randomly in space searching for chemical cues
before they retracted. These filopodia could exert forces very rarely
exceeding 4 pN when a trapped bead was kept in their random
motion (Fig. 4b). From the same neurons, the force exerted by filo-
podia after the addition of 30 mM Blebbistatin was measured
(Fig. 4c–d). In these conditions, filopodia emerging from lamellipo-
dia that had shrunk were still able to exert a force which was often
larger (Fig. 4d) and were also able to exert a significant force along a
vertical direction (compare red traces in Fig. 4b and d). Collected
data from 12 neurons show that the average force exerted by filopo-
dia was 2.7 pN in control condition and increased to 4.2 pN in the
presence of 30 mM Blebbistatin. However, filopodia in the presence
of 500 nM Nocodazole together with 30 mM Blebbistatin exerted
forces of 2.6 6 0.2 pN (Fig. 4h) similar to those observed in control
condition.
These results show that Blebbistatin reduces the amplitude of the
force exerted by lamellipodia but increases the force exerted by filo-
Table 1 | The effect of different inhibitors on themaximum force exerted by lamellipodia. Averagemaximum force exerted by lamellipodia in
control condition (second column), in the presence of 30 mMBlebbistatin (third column), 25 nMCytochalsin D (fourth column) and 500 nM
Nocodazole (fifth column) for vertical push (first row), lateral push (second row), vertical retraction (third row) and lateral retraction (fourth
row). Student t-test showed that the data significantly differs with respect to control, *P, 0.05 and **P, 0.005. Data represents mean 6
SEM
Force (pN) n $ 15 Control Blebbistatin 30 mM Cytochalasin-D 25 nM Nocodazole 500 nM
VP 10.4 6 1.2 5.8 6 1.2* 3.5 6 0.7** 0.9 6 0.1**
LP 14.1 6 1.0 6.4 6 1.1* 6.6 6 1.0* 6.0 6 0.7**
VR 10.6 6 1.0 4.0 6 1.0** 5.7 6 1.0* 1.3 6 0.3**
LR 15.5 6 1.6 7.3 6 1.0* 8.3 6 0.7* 5.3 6 0.9**
www.nature.com/scientificreports
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podia of DRG neurons (Fig. 4i); this increase of the force exerted by
filopodia is abolished by the concomitant application of Nocodazole.
Discussion
The present manuscript describes the effect of the inhibition of myo-
sin-II on the morphology, kinetics and dynamics of lamellipodia and
filopodia emerging from the soma and GCs of DRG neurons. Our
results confirm that myosin-II not only controls the retrograde flow
of actin10 but also controls and regulates the structural stability of
GCs architecture managing the coupling of actin filaments and
microtubules dynamics. Our results also show that the contractions
of the actomyosin complex formed by filaments of actin and myosin
have an active role during lamellipodia retractions. Let us now dis-
cuss more in detail these issues.
There are three isoforms of myosin-II in GCs, which have often a
different localization in GCs13,24 possibly underlying different func-
tions25,26. We examined the localization of NMIIA and NMIIB in
DRG GCs by immunostaining. We determined simultaneously the
cellular distribution of actin, tubulin and one of the two myosin
isoforms, i.e. NMIIA and NMIIB (see Fig. SI1). The staining for
Figure 3 | The effect of Blebbistatin andCytochalasin-D on the elementary events underlying force generation. (a) Average force – variance relationship
for lateral pushes in control condition (red curve) and in the presence of Cytochalasin-D (CD 25 nM, black and grey curves). (b) As in (a) but
in the presence of Blebbistatin (Bleb 30 mM, blue curve). (c) As in (a) but in the presence of Nocodazole (Noco 500 nM, green curve) (d–f)Magnification
of the z component during push in the presence of Cytochalasin-D (d), in the presence of Blebbistatin (e) and in the presence of Nocodazole (f). Original
traces were filtered by the nonlinear diffusion algorithm, resulting in a smooth component and jumps. Jumps were not detected frequently during a push
in the presence of Cytochalasin-D andNocodazole butmore often during a push in the presence of Blebbistatin. (g–i) Density of forward j1 and backward
j2 jumps during pushes in the presence of Cytochalasin-D (g), in the presence of Blebbistatin (h) and in the presence of Nocodazole (i). Because of a
residue noise, jumps with an amplitude lower than 2 nm could not be detected.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 7842 | DOI: 10.1038/srep07842 6
NMIIB was preferentially localized in the central domain and trans-
ition zone of the GCs, in agreement with previous observations10,13
and very rarely we detected staining in the filopodia. In contrast, we
observed amore diffuse staining ofNMIIA, present in the central and
transition zone of the GCs, but also in its periphery, near its leading
edge, and occasionally also in some filopodia. We analyzed also the
actin and tubulin distribution in lamellipodia emerging from the
soma of differentiating DRG neurons. Lamellipodia sprouting from
the soma had an extensive network of actin filaments interspersed
with rare filaments of microtubules. Also in these lamellipodia stain-
ing of NMIIA was clearly present at their leading edge, while staining
for NMIIB was more restricted near the soma and rarely extended to
the leading edge of lamellipodia.
After treatment with 20–50 mMBlebbistatin, a powerful inhibitor
of both myosin-II isoforms27, lamellipodia emerging from the soma
and fromGCs distant from the soma, changed theirmorphology, lost
their sheet-like structure and appeared ‘filopodish’ (Fig. 5a–d). After
Blebbistatin treatment (Fig. 5d–f) sparse actin filaments were clearly
visible and they did not appear to be joined by the usual actin net-
work. Untreated GCs at the tip of long neurites had the core of
microtubules surrounded by a mesh of actin filaments and very
rarely microtubules entered the filopodia, which were primarily
composed of actin filaments. After treatment with Blebbistatin, the
terminal ends of neurites were not only composed of actin filaments
but also of microtubules at the most distant GCs tips (Fig. 5e and f).
The average number of filopodia per GCs in untreated DRG neurons
was 7.5 6 1.2 and was 6.8 6 1.2 after treatment with 30 mM
Blebbistatin (Fig. 5g).
If the mean number of filopodia per GC was not significantly
affected by myosin-II inhibition, treatment with Blebbistatin had a
profound effect on the distribution of microtubules inside the filo-
podia: in control condition the fraction of filopodia emerging from
GCs exhibiting a staining for microtubules was 0.07 6 0.02 (Fig. 5h,
red bar) but after Blebbistatin treatment it increased to 0.42 6 0.04
(Fig. 5h, blue bar), showing that inhibition of NMII elevated the
presence of microtubules inside filopodia. Filaments of NMII could
cross-link actin filaments providing the network with a diffuse lateral
connectivity gluing together the sparse actin filaments resulting in a
sheet-like overall structure. Inhibition of NMII destroyed this con-
nectivity leading to the observed ‘filopodish’ appearance.
Contractions of the actomyosin complex play a fundamental role
in several cellular processes such as changes of the cellular shape28,
cell migration25,29 cell-cell and cell-matrix adhesion30, cell division
and cell differentiation11. During the cycles of protrusion/retraction
here analyzed (Fig. 1) lamellipodia ruffle after their maximal protru-
sion. These events seem to precede the usual lamellipodium retrac-
tion and, given the localization of NMIIA at the lamellipodium
periphery, they are most likely originated from contractions of the
actomyosin. These observations suggest a dual and complementary
role for the two myosin-II isoforms: NMIIA located also at the peri-
phery of lamellipodia, undergoing ruffle formation, could mediate a
contraction of the actomyosin complex initiating retraction and
NMIIB locatedmore centrally near the transition region of the lamel-
lipodium could control actin turnover10. Numerical simulations of
the actomyosin complex have shown that generated stresses are over-
whelmingly contractile and force chains play a major role31–33.
The ruffle formed during the retraction of the lamellipodia could
be the artifact of the 2D substrate. Lamellipodia ruffle forms because
of inefficient formation of focal adhesion34, while in 3D matrices the
motility of the cell switches between adhesion-dependent mesench-
ymal (elongated) and adhesion-independent amoeboid (rounded)
cell motility35.
When NMII was inhibited by Blebbistatin, we observed two sig-
nificant morphological changes: lamellipodia lost their sheet-like
appearance and became ‘filopodish’ (Fig. 5a and b) and filopodia
emerging from GCs had a higher proportion of microtubules inside
(Fig. 5g and h) in agreement with previous findings36. These mor-
phological changes were mirrored by the observation that filopodia
treated with Blebbistatin exert a larger force (Fig. 4). The mean
flexural rigidity of microtubules is 2.2 3 10223 Nm2 which is almost
1000 times larger than that of actin filaments and equals to 7.3 3
10226 Nm237: therefore, filopodia from GCs treated with Blebbistatin
are expected to have a larger stiffness and to exert a larger force.
When microtubule polymerization was concomitantly inhibited by
Nocodazole (Fig. 4), filopodia exerted a force comparable to that
observed in control condition.
These observations are consistent with the emerging view that
inhibition of NMII promotes axon regeneration13. Chondroitin sul-
fate proteoglycans (CSPGs), major components of the extracellular
matrix in the CNS, inhibit axonal regeneration after injury, through
the activation ofNMII by phosphorylation of regulatorymyosin light
chain (RLC) ultimately remodeling cytoskeletal dynamics38.
Inhibition of NMII by Blebbistatin promotes axon outgrowth irre-
spective of the presence of CSPGs in both CNS and PNS neurons13,38
providing therefore a promising pharmacological/chemical treat-
ment for neuronal regeneration.
The results reported in the present manuscript confirm the essen-
tial role of NMII in cytoskeletal dynamics and in the orchestration of
both actin and MT dynamics in GCs12,13,38. As shown in Fig. 5, after
Blebbistatin treatment, the proportion of filopodia with MTs inside
them increases from 0.07 to 0.42 suggesting that Blebbistatin has
facilitated the growth of MTs filaments. The biochemical pathway
through which NMII affects MT dynamics is not known and it is
probably not involving the Rho-kinase (ROCK)13: indeed, inhibition
of NMII promotes axon growth but not the inhibition of the Rho-
ROCK pathway. On the other hand, repulsive guidance molecule
(RGMa) induces neurite outgrowth inhibition through RhoA and
Rho-kinase dependent phosphorylation of NMIIA RLC resulting
in F-actin reduction39. These findings suggest, therefore, mechanis-
tically distinct actin- and MT-based GC responses.
Methods
Neuron preparation.Wistar rats at postnatal days 10 to 12 (P10–P12) were sacrificed
by decapitation after anesthesia with CO2 in accordance with the Italian Animal
Welfare Act. The Ethics Committee of the International School for Advanced Studies
(SISSA-ISAS) has approved the protocol (Prot.n. 2189-II/7). After dissection, Dorsal
RootGanglias (DRG)were incubatedwith trypsin (0.5 mg/ml; Sigma-Aldrich,Milan,
Italy), collagenase (1 mg/ml; Sigma-Aldrich) andDNase (0.1 mg/ml; Sigma-Aldrich)
in 5 mlNeurobasal medium (Gibco, Invitrogen,Milan, Italy) in a shaking bath (37uC,
Table 2 | Jump Frequency and amplitude. Amplitudes of positive jumps (j1, second row) and negative jumps (j2, third row), frequency of
positive jumps(A1, fourth row) and negative jumps (A2, fifth row) of the control (second column), Blebbistatin (third column), Cytochalasin-D
12.5 nM,(fourth column), Cytochalasin-D 25 nM (fifth column) and Nocodazole (sixth column) respectively. Power analysis is used to
determine a required sample size. *indicates sufficient sample size for 80% power assuming a 5% significance level
Control Blebbistatin 30 mM (n 5 4) Cytochalasin-D 12.5 nM (n 5 3) Cytochalasin-D 25 nM (n 5 4) Nocodazole 500 nM (n 5 3)
j1 (nm) 5.10 3.05* 3.60* 2.46* 4.9
j2 (nm) 4.90 2.96* 3.60 2.35* 5.4
A1 events/s 157.3 135.10* 138.26 110.99* 56.04*
A2 events/s 155.5 125.68* 157.74 153.25 51.60*
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 7842 | DOI: 10.1038/srep07842 7
Figure 4 | The effect of Blebbistatin on the force exerted byDRG filopodia. (a) Images of a bead trapped in front of a filopodium emerging from aGCs of
DRG neuron. At t1 the bead is in the optical trap and at t2–t3 the filopodium pushes the bead. The cross indicates the centre of the optical trap.
(b) The three components Fx, Fy and Fz of the force exerted by the filopodium. (c–d) As in (a–b) but in the presence of Blebbistatin (Bleb 30 mM, blue).
(e–f) As in (a–b) but in the presence of Nocodazole (Noco 500 nM). (g–h) As in (a–b) but in the presence of Nocodazole1Blebbistatin (Blebb1Noco).
(i) Filopodia force in Control, in presence of Blebbistatin, Nocodazole and Nocodazole1Blebbistatin. By using the student t-test, the force measured in
the presence of inhibitors was lower than the one measured in control condition with a significance *P, 0.005. Data represent mean 6 SEM. The trap
stiffness is kx,y 5 0.10 pN/nm, kz 5 0.03 pN/nm. All the data were checked with chi-square test for Normal distribution before applying the student’s t
test.
www.nature.com/scientificreports
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Figure 5 | The effect of Blebbistatin on GCs morphology. (a–b) Lamellipodium emerging from a DRG neuron in control condition and after treatment
with 30 mM Blebbistatin, respectively. Note the ‘filopodish’ appearance of the lamellipodia after Blebbistatin treatment. (c) Immunostaining of DRG
lamellipodium in control condition for actin (green) and tubulin (blue) staining. (d) As in (c) but in the presence of 30 mM Blebbistatin.
(e) Immunostaining of a GC after Blebbistatin treatment for actin, NMIIA and tubulin and merge of the three staining. Arrows and arrowheads indicate
filopodia with andwithout a clear staining for tubulin, respectively. (f) Immunostaining of aGC after Blebbistatin treatment for actin, NMIIB and tubulin
andmerge of the three staining. (g) The average number of filopodia per GC before (red) and after treatment with Blebbistatin (blue). (h) The fraction of
filopodia with a staining for microtubules in control condition (red bar) and after Blebbistatin treatment (blue bar). Student t-test showed that data
significantly differ when compared to the control, P , 0.05. All data were checked with chi-square test for Normal distribution before applying the
student’s t test. Scale bar, 5 mm.
www.nature.com/scientificreports
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Figure 6 | Characterization of lamellipodial protrusion/retraction cycles and of vertical motion. (a) From left to right: three images of the
lamellipodium undergoing cyclic waves of protrusion (t2) and retraction (t1 and t3) in control condition; the white dotted line represents the leading edge
of the lamellipodia. Scale bar, 5 mm. (b) Diagram of the method used for the semi-automatic detection of protrusion/retraction cycles. See text for more
details. (c) Time evolution of the distance of the lamellipodium leading edge from the reference point indicated by the red cross in (b). Local maxima and
minima represent maximal protrusion and retraction, respectively. (d) Stack of 6 images acquired from 6 focal planes at distance h from the coverslip
where neurons were cultured. Scale bar, 5 mm. Red and blue arrows indicate section of lamellipodia above and below the focused plane, respectively. The
pixels above focus appear brighter and the pixels below appear darker. (e) Fractional pixels in focus of lamellipodia in different focal planes (h 5 2, 3 and
4 mm) above the coverslip indicating the fractional reached height by lamellipodia. The continuous solid lines are smoothing over a time window of
100 s.
www.nature.com/scientificreports
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35–40 min). After mechanical dissociation, they were centrifuged at 300 rpm,
resuspended in culture medium, and plated on poly-L-lysine-coated (0.5 mg/ml;
Sigma-Aldrich) coverslips. Neurons were incubated for 24 h to 48 h and nerve
growth factor (50 ng/ml; Alomone Labs, Jerusalem, Israel) was added before
performing the measurements.
Quantification of lamellipodia motility. Z-stack phase contrast imaging was
performed to quantify the kinetics of protrusion/retraction cycles of lamellipodia in
lateral and axial directions. Stacks of images at a frequency of 0.1–1 Hzwere acquired.
Every stack of images was composed of an image, focused at the plane containing the
coverslip where neurons were cultured and images focused at 1,2,3,4,5 and 6 microns
above the coverslip. Two algorithms were developed: Algorithm I was designed to
quantify in a semi-automatic way the time course of protrusion/retraction cycles and
Algorithm II was designed to quantify the vertical motion of lamellipodia during
these cycles.
Algorithm I. Images focused on the coverslip plane at different times of the
protrusion/retraction cycles (Fig. 6a, t1–t3) were analyzed: edges were extracted
using standard procedures40 and the contour of the neuron was obtained (red line
in Fig. 6b). A reference point at the base of the lamellipodium was selected (red
cross in Fig. 6b) and an angle covering the lamellipodium was drawn (green
shadow in Fig. 6b). The mean distance between the red cross and the points
forming the detected contour inside the green shadow was computed and plotted
(Fig. 6c). In this plot, representing the mean distance of the lamellipodium
leading edge from the reference point, local maxima and minima were detected
(green and red asterisks, respectively, in Fig. 6c). The interval between a suc-
cessive green and red point was taken as the period of that protrusion/retraction
cycle.
Algorithm II. Algorithm II was based on classical depth-from-focus algorithms
introduced in Computer Vision16 to recover 3D information from stacks of images
acquired at different focal planes. These algorithms were used to restore the
lamellipodia motion in the vertical direction. Briefly, for each pixel (i,j) and for
each image I(i,j,h) acquired at a focal plane h microns above the coverslip, the
gradient = I(i,j,h) was computed. The point at location (x,y) has the height h if the
feature at point (x,y) is in focus on the plane h, determined as the plane for which
= I(i,j,h) has the maximum value. Images of the neuron taken from different focal
planes separated by 1 mm are shown in Fig. 6d (h 5 1,…,6 mm) from which
=I(i,j,h) was computed.
In order to characterize the vertical motion ability of a lamellipodium for each
value of h, we computed the fraction of pixels - in a given region of interest - in
focus at the height h (Fig. 6e). In this way we could quantify the effect of
Blebbistatin, Cytochalasin-D and Nocodazole on the ability of lamellipodia to lift
up vertically.
Force Measurements. The Optical Tweezers (OT) set-up used for force
measurements, the procedures followed to compute the Force-Velocity (Fv) relations
and the elementary events were as previously described18,19. The optical tweezers set-
up was built as described in Ref. 22.
Computation of Fv relationships. The velocity v 5 (vx, vy, vz) of the bead was
obtained by numerical differentiation of its sampled position x 5 (x(n), y(n), z(n)) n
5 1,…N. Numerical differentiation was computed either by convolution of the
position components x(n), y(n) and z(n) with the derivative of a Gaussian filter 1/
[s(2p)1/2] exp(2t2/s2) (Gaussian filtering) or by Linear regression. Gaussian filters
corresponding to cut-off frequencies of 0.2, 1 and 10 Hz were used. Further details
can be found in Ref. 19.
Jumps determination by non linear diffusion filtering. In order to detect jumps, we
used an algorithm based on non linear diffusion41,42. The algorithm is based on the
Toolbox of Frederico D’Almeida (see http://www.mathworks.com/matlabcentral/
fileexchange/3710-nonlinear-diffusiontoolbox). Further details can be found in Ref.
18.
Immunostaining. Cells were fixed in 4% paraformaldehyde containing 0.15%
picric acid in phosphate-buffered saline (PBS), saturated with 0.1 M glycine,
permeabilized with 0.1% Triton X-100, saturated with 0.5% BSA in PBS (all from
Sigma-Aldrich, St.Louis, MO) and then incubated for 1 h with primary antibodies:
mouse monoclonal antibody against neuronal class III b-tubulin-TUJ1 (Covance,
Berkeley, CA) and rabbit polyclonal antibodies against myosin-IIA and IIB (both
from Sigma-Aldrich, St.Louis, MO). The secondary antibodies were goat anti-
rabbit 594 Alexa (Invitrogen, Life Technologies, Gaithersburg, MD, USA) and
anti-mouse IgG2a biotynilated (Santa Cruz Biotechnology, Santa Cruz, CA) and
the incubation time was 30 min. F-actin was marked with Alexa Fluor 488
phalloidin, whereas biotin was identified by Marina Blue-Streptavidin (Invitrogen,
Life Technologies, Gaithersburg, MD, USA) and incubated for 30 min. All the
incubations were performed at room temperature (20–22uC). Cells were examined
using a Leica DMIRE2 confocal microscope (Leica Microsystems GmbH,
Germany) equipped with DIC and fluorescence optics, diode laser 405 nm,
Ar/ArKr 488 nm and He/Ne 543/594 nm lasers. The fluorescence images (1024 3
1024 pixels) were collected with a 633 magnification and 1.3 NA oil-immersion
objective. Leica LCS Lite and Image J by W. Rasband (developed at the U.S.
National Institutes of Health and available at http://rsbweb.nih.gov/ij/) were used
for image processing.
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